CANCER IS THE ULTIMATE BIOLOGICAL EQUALIZER
Cancer and its derivative diseases are not selective of race, status, money, or gender. Presidents, Doctors, Lawyers, or the man and woman on the street—every human life is subjected without exception.
"All financial gain pales into absolute insignificance when cancer strikes a human being. By placing this complete continuous-graphene liquid biopsy and theranostic architecture directly into the open public domain, all personal monetary interest is voluntarily forfeited."
This deliberate irrevocable disclosure establishes universal prior art. It permanently ring-fences the underlying physics against proprietary corporate lockups, predatory monopoly patents, and artificial clinical price walls—guaranteeing that label-free single-cell oncology remains forever free and unencumbered for global medical research.
Pristine Graphene Liquid Biopsy & Immediate Targeted Theranostics
By deploying continuous cryogenic acoustic fissured (CAF) Grade S monolayer graphene ($I_\text{D}/I_\text{G} < 0.015$), hydraulic resistance drops to near zero ($R_\text{pore} \propto h_0 \approx 0.34\text{ nm}$). This enables tangential cross-flow filtration of Circulating Tumor Cells (CTCs) under near-zero shear stress ($\tau_\text{wall} \ll 1.5\text{ Pa}$), completely preventing cell lysis. Captured cells undergo direct on-membrane in-situ transcriptomic sequencing (scRNA-seq), immediately feeding mutation parameters to non-covalently stacked ($\pi\text{--}\pi$) aptamer nanocarriers for targeted photothermal ablation ($42\text{--}45^\circ\text{C}$).
Multi-Channel Biophysical & Trapping Simulation
Real-time dynamic visualization of hemodynamic shear, Brownian diffusion, and physical cell trapping
In Brownian Mode, sub-micron viral capsids deviate from laminar fluid streamlines via thermal Brownian diffusion, colliding with the unoxidized carbon lattice where delocalized $\pi$-electrons trigger immediate non-covalent pinning.
In Cellular Mode, rigid CTCs roll along the atom-thin pore mouths under cross-flow lift, preventing shear-induced lysis while compliant erythrocytes deform freely through the apertures.
Conventional polymer track-etched filters have channel lengths $L \approx 10\text{--}20\text{ }\mu\text{m}$. Poiseuille's Law dictates pressure drops proportional to length:
Near-zero thickness eliminates shear walls inside the aperture, allowing cells to gently pass without friction rupture.
Strong predicate foundation via Menarini Silicon Biosystems CELLSEARCH® CTC System (FDA cleared under 21 CFR 866.6020). Both systems isolate rare epithelial CTCs from whole blood to predict progression-free and overall survival.
Traditional graphene synthesized via the Hummers method leaves hazardous hydrazine and heavy metal residues, failing ISO 10993-5 (Cytotoxicity). CAF's mechanical exfoliation produces zero-chemical residue output.
Under FDA’s In Vitro Companion Diagnostic (CDx) guidance, the microfluidic chip pairs directly with targeted NIR nanocarriers, enabling synchronized Phase I/II safety-efficacy trials with reduced patient cohorts.
Clear quantitative analytical endpoints: CTC enumeration recovery ($>95\%$), scRNA gene-concordance ($r > 0.98$ vs surgical biopsy), and zero off-target photothermal ablation at $808\text{ nm}$.
Zero solvents, inert unfunctionalized carbon.
Grade S intrinsic tensile strength: 130 GPa.
Inline Raman sorting guarantees pore batch uniformity.
First-Principles Biomechanics & Quantum Optics Proofs
Because membrane thickness $h_0 = 0.34\text{ nm}$ is negligible compared to pore diameter ($8\text{ }\mu\text{m}$), frictional pipe flow loss vanishes entirely. Total pressure drop is restricted purely to convergent entrance and exit losses.
Cortical tension $T_c$ of rigid metastatic CTCs ($T_c \approx 1.5\text{--}3.0\text{ mN/m}$) is an order of magnitude higher than flexible erythrocytes ($T_c \approx 0.02\text{ mN/m}$). Operating at $\Delta P = 12\text{ mmHg}$ forces RBC transmission while rejecting 100% of intact CTCs.
Unbroken $sp^2$ graphene lattices exhibit a high optical absorption cross-section $\sigma_\text{abs}$ at near-infrared wavelengths. A gentle $1.5\text{ W/cm}^2$ laser pulse heats target cancer clusters into the irreversible apoptotic window ($42.5\text{--}45^\circ\text{C}$) in sub-millimeter radii without damaging adjacent healthy tissue.
Pilot Plant Construction & Industrial Scale-Up Phase
Tangible clinical microfluidic cartridges cannot be distributed at this stage. Physical evaluation units for research consortia and FDA 510(k) trials will become available strictly following the engineering construction and validation of the continuous-flow CAF Pilot Plant. We invite industrial partners, sovereign medical funds, and clinical institutions to join the pre-construction consortium.